(Q50631541)

16 March 2018

title

Comparison of the cochlear toxicity of sodium ethacrynate, furosemide, and the cysteine adduct of sodium ethacrynate in cats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1129798

24 August 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

8 October 2023

author name string

R. D. Brown

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1129798

24 August 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1129798

24 August 2022

publication date

1 February 1975

1 reference

16 March 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0041008X75901623?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

https://api.elsevier.com/content/article/PII:0041008X75901623?httpAccept=text/plain

8 October 2023

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Toxicology and Applied Pharmacology

8 October 2023

published in

1 reference

16 March 2018

volume

31

1 reference

16 March 2018

issue

2

1 reference

16 March 2018

page(s)

270-282

1 reference

16 March 2018

RENOTROPIC CHARACTERISTICS OF ETHACRYNIC ACID: A PHENOXYACETIC SALURETIC-DIURETIC AGENT

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Cochlear N1 depression produced by the sodium salts of ethacrynic acid and its cysteine adduct

8 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Effects of intra-arterially and intravenously administered ethacrynic acid and furosemide on cochlear N 1 in cats

8 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Evaluation of a new oral diuretic agent. Furosemide (Lasix)

8 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

8 October 2023

Deafness from furosemide

12

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

ADDITION OF THE SALURETIC ACTION OF FUROSEMIDE TO THE SALURETIC ACTION OF CERTAIN OTHER AGENTS

8 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Ethacrynic acid and furosemide. Diuretic and hemodynamic effects and clinical uses

8 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Physiologic and clincical observations on furosemide and ethacrynic acid

8 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Furosemide and Ethacrynic Acid in Renal Insufficiency

8 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

STUDIES ON ETHACRYNIC ACID IN PATIENTS WITH REFRACTORY EDEMA

8 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Ototoxicity of Ethacrynic Acid and Aminoglycoside Antibiotics in Uremia

8 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Ototoxicity of New and Potent Diuretics: A Preliminary Study

8 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Transient and permanent deafness following treatment with ethacrynic acid in renal failure

8 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Acute transient hearing loss after ethacrynic acid therapy

8 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Ototoxicity Induced by Furosemide

8 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Protein Binding and Vascular Activity of Diazoxide

8 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Furosemide. A clinical evaluation of its diuretic action

8 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

Differences in the acute effects of furosemide and ethacrynic acid in man

8 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

8 October 2023

Deafness from Furosemide

29

1 reference

https://api.crossref.org/works/10.1016/0041-008X(75)90162-3

8 October 2023

Identifiers

1 reference

16 March 2018

1 reference

16 March 2018